Últimas noticias sobre ATI (NYSE:ATI) Bolsa

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

Allegheny Technologies

ATI Inc

ATLANTIS GAMING CORP by Atlantis Gaming Corporation

Atlantis Gaming Corp

Archimedes Tech SPAC Partners II Co. - Ordinary Shares

Archimedes Tech SPAC Partners II Co

Archimedes Tech SPAC Partners II Co. - Unit

Archimedes Tech SPAC Partners II Co. - Warrant

ATI PHYSICAL THERAPY A by ATI Physical Therapy, Inc.

ATI Physical Therapy Inc

ATI Physical Therapy Inc Warrants (10/08/2027)

ATI Networks Inc

ANALYTIXINSIGHT INC by Analytixinsight Inc

AnalytixInsight Inc

WIIM

ATI shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 adjusted EPS guidance with its midpoint below estimates.

<h3>Gainers</h3>
<ul>
<li>Erayak Power Solution Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAYA#NASDAQ">RAYA</a>) stock moved upwards by 38.3% to $0.18 during Thursday's pre-market session. The company's market cap stands at $5.7 million. </li>
<li>Caesarstone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTE#NASDAQ">CSTE</a>) shares moved upwards by 18.55% to $2.3. The company's market cap stands at $67.0 million. </li>
<li>Masco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) shares increased by 11.07% to $73.01. The market value of their outstanding shares is at $13.8 billion. As per the press release, Q2 earnings came out today. </li>
<li>Rentokil Initial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTO#NYSE">RTO</a>) shares moved upwards by 10.11% to $25.37. The market value of their outstanding shares is at $11.5 billion. </li>
<li>GEE Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/JOB#AMEX">JOB</a>) shares moved upwards by 9.94% to $0.22. The company's market cap stands at $21.8 million. </li>
<li>American Superconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NASDAQ">AMSC</a>) shares moved upwards by 9.89% to $48.29. The market value of their outstanding shares is at $1.9 billion. As per the press release, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock decreased by 11.7% to $0.05 during Thursday's pre-market session. The market value of their outstanding shares is at $1.9 million. </li>
<li>Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) shares fell 11.32% to $5.25. The company's market cap stands at $1.4 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) shares fell 10.55% to $0.16. The company's market cap stands at $3.2 million. </li>
<li>ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) shares declined by 8.56% to $86.18. The market value of their outstanding shares is at $13.2 billion. The company's, Q2 earnings came out today. </li>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) stock declined by 7.39% to $6.65. The market value of their outstanding shares is at $12.8 million. </li>
<li>Builders FirstSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) shares declined by 7.23% to $117.0. The market value of their outstanding shares is at $13.9 billion. As per the news, the Q2 earnings report came out today. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMSC

BGLC

BLDR

CSTE

EOSE

RAYA

WLGS

12 Industrials Stocks Moving In Thursday's Pre-Market Session

Agreement strengthens&nbsp;ATI's role as leading aerospace structures supplier
 &nbsp;

News

Boeing Taps ATI For Long-Term Titanium Supply Across Narrowbody And Widebody Programs, Including Third-Party Subsidiaries

ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) narrows FY2025 Adj EPS guidance from $2.87-$3.09 to $2.90-$3.07 vs $2.99 analyst estimate..

Guidance

ATI Narrows FY2025 Adj EPS Guidance from $2.87-$3.09 to $2.90-$3.07 vs $2.99 Est

ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) is looking for Q3 Adj EPS of $0.69-$0.75 vs $0.75 analyst estimate..

ATI Sees Q3 Adj EPS $0.69-$0.75 vs $0.75 Est

ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.71 by 4.82 percent. This is a 23.33 percent increase over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $1.140 billion which missed the analyst consensus estimate of $1.149 billion by 0.77 percent. This is a 4.11 percent increase over sales of $1.095 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

ATI Q2 Adj. EPS $0.74 Beats $0.71 Estimate, Sales $1.140B Miss $1.149B Estimate

AAMI

AAPL

ABBV

ACCO

AGCO

AGIO

ALGM

ALNY

AMZN

APLS

APPF

APTV

ARGX

ASUR

ATEC

ATHM

AUPH

AXTI

BBVA

BCPC

BFAM

BIGC

BIIB

BJRI

BOOT

BSAC

CABO

CACC

CCCS

CCEC

CDRO

CIGI

CLAR

CMCSA

CMPS

CMRE

COHN

COHU

COIN

COLM

CORT

CRAI

CUBE

CVCO

CWST

DFIN

DINO

DOUG

DSGR

Earnings Scheduled For July 31, 2025

In the current session, the stock is trading at $96.35, after a 1.43% increase. Over the past month, ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) stock increased by 13.52%, and in the past year, by 45.23%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1753732830_0.png" alt="Past Year Chart" />

<h3>A Look at ATI P/E Relative to Its Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
ATI has a lower P/E than the aggregate P/E of 131.82 of the Aerospace &amp; Defense industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1753732830_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

A Look Into ATI Inc's Price Over Earnings

The defense sector is on fire in 2025 — and investors are watching earnings season for signs <a href="https://www.benzinga.com/news/25/07/46344520/defense-stocks-outperform-tech-trump-budget-boost">the rally can continue.</a>
The iShares U.S. Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITA#NYSE">ITA</a>) is up 33% year-to-date through July 16, on track for its best annual return since 2013. 
The fund gained 25% in the first half alone, outperforming both the Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) and the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) by double-digit margins.
See Also: <a href="https://www.benzinga.com/markets/equities/25/07/46267993/lockheed-martin-tops-defense-peers-in-capital-efficiency-but-market-isnt-impressed">Lockheed Martin Tops Defense Peers In Capital Efficiency — But Market Isn&#8217;t Impressed</a>
<h2 class="wp-block-heading">Washington Fueled The Rally—Now Investors Want Results</h2>
Investors have already bought the rumors—now they want the facts. The explosive rally in defense stocks has been fueled by a fundamental shift in Washington's priorities and the rising tide of global tensions.
On July 4, President Donald Trump signed the "One Big Beautiful Bill Act," a sweeping defense package that injects $156.2 billion into the Pentagon—the largest single-year boost in over a decade. 
The bill directs tens of billions toward areas that could redefine the future of warfare and defense contracting. Shipbuilding alone receives $29.2 billion, while $24.4 billion is allocated to integrated air and missile defense—what the administration has dubbed the "Golden Dome" initiative. 
Another $25.4 billion is earmarked to strengthen munitions production and shore up supply chain resilience, and $16 billion will go toward scaling low-cost weapons systems. 
The budget also includes $10.8 billion to modernize the U.S. nuclear arsenal and $8.6 billion to support new air superiority projects.
<h3 class="wp-block-heading">Q2 2025 Defense Earnings Preview: Who Reports and When</h3>
Defense stocks slated to report earnings by the end of July include: 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>Earnings Date</th>
<th>YTD % Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>)</td>
<td>Wed Jul 16 (After-Market)</td>
<td>+21.48%</td>
</tr>
<tr>
<td>General Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>)</td>
<td>Thu Jul 17 (Pre-Market)</td>
<td>+58.81%</td>
</tr>
<tr>
<td>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>)</td>
<td>Tue Jul 22 (Pre-Market)</td>
<td>+29.12%</td>
</tr>
<tr>
<td>Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>)</td>
<td>Tue Jul 22 (Pre-Market)</td>
<td>-3.25%</td>
</tr>
<tr>
<td>Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>)</td>
<td>Tue Jul 22 (Pre-Market)</td>
<td>+10.37%</td>
</tr>
<tr>
<td>General Dynamics Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>)</td>
<td>Wed Jul 23 (During-Market)</td>
<td>+13.64%</td>
</tr>
<tr>
<td>L3Harris Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>)</td>
<td>Thu Jul 24 (Pre-Market)</td>
<td>+25.02%</td>
</tr>
<tr>
<td>Textron Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>)</td>
<td>Thu Jul 24 (During-Market)</td>
<td>+9.60%</td>
</tr>
<tr>
<td>Hexcel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>)</td>
<td>Thu Jul 24 (After-Market)</td>
<td>-6.14%</td>
</tr>
<tr>
<td>Woodward Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>)</td>
<td>Mon Jul 28 (After-Market)</td>
<td>+51.46%</td>
</tr>
<tr>
<td>The Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>)</td>
<td>Tue Jul 29 (During-Market)</td>
<td>+29.40%</td>
</tr>
<tr>
<td>Leonardo DRS Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRS#NASDAQ">DRS</a>)</td>
<td>Wed Jul 30 (During-Market)</td>
<td>+49.25%</td>
</tr>
<tr>
<td>Sturm, Ruger &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGR#NYSE">RGR</a>)</td>
<td>Wed Jul 30 (After-Market)</td>
<td>+0.66%</td>
</tr>
<tr>
<td>Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>)</td>
<td>Thu Jul 31 (Pre-Market)</td>
<td>+67.99%</td>
</tr>
<tr>
<td>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>)</td>
<td>Thu Jul 31 (Pre-Market)</td>
<td>+63.33%</td>
</tr>
<tr>
<td>Huntington Ingalls Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HII#NYSE">HII</a>)</td>
<td>Thu Jul 31 (During-Market)</td>
<td>+33.78%</td>
</tr>
</tbody>
</table>
</figure>
<h2 class="wp-block-heading">What Analysts Are Watching In Defense Earnings</h2>
With defense stocks sitting at record highs, Goldman Sachs analyst Noah Poponak cautions that expectations are running hot. 
In a July 16 preview, Poponak and his team mapped out where they see opportunity across the aerospace and defense landscape—and where the cracks might show.
<h4 class="wp-block-heading">Aerospace: Boeing Back in Focus</h4>
Goldman remains upbeat on aerospace industry, especially Boeing Co. , which delivered 60 aircraft in June—a clear improvement over earlier production trends. 
Supplier sentiment has also turned more positive, with stronger communication and steadier order flow.
Still, aircraft demand continues to exceed supply, a dynamic expected to last well into the next decade, supporting pricing power and margins across the industry.
&#8220;We like aerospace original equipment where supply remains below demand, there is multi-year growth visibility, and Boeing continues to improve production and delivery rates.&#8221; Poponak said. 
The aftermarket segment is thriving, growing faster than global available seat miles (ASMs) for four straight quarters. Goldman attributes this to pent-up demand, aging fleets, and strong pricing—a combination that should keep the sector buoyant even as near-term air travel shows signs of softening.
The business jet space looks more idiosyncratic. Leading indicators are plateauing, and while new production remains disciplined, Goldman expects fewer broad-based tailwinds going forward. Still, aftermarket sales here remain high quality and margin-rich.
<h4 class="wp-block-heading">Defense Tech: Emerging Winners</h4>
Goldman favors non-traditional defense tech firms, which stand to benefit from a Pentagon pivot toward nimble, cost-effective systems. 
While reconciliation funding may not hit second-quarter results directly, it's likely to surface in earnings call commentary—and eventually in backlog growth.
"Defense tech companies appear to be on the verge of receiving significant funding relative to their size," Poponak said.
Despite near-record Department of Defense funding, Goldman is cautious on legacy hardware contractors. 
Programs like the F-35 face funding cuts, and the Pentagon is pushing for tougher terms across the industry. Instead, Goldman prefers companies aligned with funded priorities like shipbuilding and missile defense.
<h4 class="wp-block-heading">Government IT: Pressure Mounts</h4>
In government IT, the risk is rising. DOGE contract reviews are leading to cancellations—most notably at Booz Allen Hamilton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>). Margins, bookings, and guidance could all face pressure this quarter, particularly for firms reliant on traditional service contracts.
<h3 class="wp-block-heading">Goldman's Top Defense Picks And Red Flags For Q2</h3>
<ul class="wp-block-list">
<li>TransDigm (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>) – Strong aftermarket growth, upside to earnings, and capital flexibility.</li>
<li>CAE Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) – Valuation play with improving execution under new management.</li>
<li>L3Harris – Well-positioned for growth; exposure to missile defense spending.</li>
<li>Huntington Ingalls – Beneficiary of shipbuilding funds, improving labor dynamics.</li>
</ul>
Stocks facing headwinds:
<ul class="wp-block-list">
<li>Booz Allen – DOGE scrutiny, slowing growth, and mounting contract risks.</li>
<li>Lockheed Martin – Uncertainty around core programs and contracting terms.</li>
<li>SAIC Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NYSE">SAIC</a>) – Back-end loaded year with potential margin compression.</li>
<li>V2X Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVX#NYSE">VVX</a>) – Weak first quarter, high execution risk in the second half.</li>
</ul>
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/25/07/46445885/bitcoin-hit-150k-before-retesting-100k-this-answer-narrowly-wins-new-poll">Will Bitcoin Hit $150K Before Retesting $100K? This Answer Narrowly Wins New Poll </a></li>
</ul>
Image: Shutterstock

Analyst Color

Equities

Large Cap

Sector ETFs

Analyst Ratings

iShares Dow Jones US Aerospace & Defense Index Fund

SAIC

Defense Stocks Head Into Earnings At Record Highs — Is The Boom Just Beginning?

Susquehanna analyst Charles Minervino maintains ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) with a Positive and raises the price target from $73 to $105.

Price Target

Susquehanna Maintains Positive on ATI, Raises Price Target to $105

IperionX Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPX#NASDAQ">IPX</a>) shares surged Thursday after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g45790807/iperionx-awarded-u-s-department-of-defense-sbir-phase-iii-contract-for-up-to-us-99m" rel="noreferrer noopener">secured a major U.S. Department of Defense</a> contract to supply domestically produced titanium parts for military use.
The $99 million Small Business Innovation Research (SBIR) Phase III Indefinite Delivery, Indefinite Quantity (IDIQ) agreement enables the Pentagon to order titanium components directly from IperionX.
The contract permits U.S. defense agencies to commission task-specific orders as part of the &#8220;Low-Cost Domestic Titanium for Defense Applications&#8221; effort.
Early task orders will involve high-performance titanium fasteners manufactured at IperionX&#8217;s Virginia campus using proprietary technologies. The project supports skilled local jobs while advancing U.S. defense readiness.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/05/45667868/top-2-materials-stocks-that-are-ticking-portfolio-bombs" rel="noreferrer noopener">Top 2 Materials Stocks That Are Ticking Portfolio Bombs</a>
The agreement aligns with federal priorities to boost the supply of strategic materials from domestic sources. Future task orders could include advanced aerospace parts, positioning IperionX as a long-term supplier for military-grade titanium.
&#8220;Securing this Phase III contract is a pivotal milestone for IperionX,&#8221; said Anastasios (Taso) Arima, the company&#8217;s CEO. &#8220;It validates the performance of our technologies and underscores the Department of Defense&#8217;s commitment to reshore an all-American titanium supply chain.&#8221;
Relevant ETFs include SPDR S&amp;P Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XAR#NYSE">XAR</a>) and iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>).
Price Action: IPX shares are trading 23.79% higher at $30.23 at Thursday&#8217;s last check.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45774621/lucid-strikes-deal-to-use-us-sourced-graphite-in-future-evs-starting-2028" target="_blank" rel="noreferrer noopener">Lucid Strikes Deal To Use US-Sourced Graphite In Future EVs Starting 2028</a></li>
</ul>

Contracts

IperionX Rockets 23% After Securing $99M Defense Contract For Domestic Titanium

ATI Signs Multi-Year Agreement With Airbus To Supply Titanium Plate, Sheet And Billet

KeyBanc Capital Markets analyst Philip Gibbs downgraded ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) <a href="https://www.benzinga.com/quote/ATI/analyst-ratings" target="_blank" rel="noreferrer noopener">from Overweight to Sector Weight</a>.
At the beginning of May, ATI reported first-quarter results, with aerospace and defense sales of $754 million, <a href="https://www.benzinga.com/pressreleases/25/05/n45130989/ati-announces-first-quarter-2025-results" target="_blank" rel="noreferrer noopener">representing 66% of sales.</a>
Gibbs has increased ATI&#8217;s 2025 estimates, citing stronger-than-expected demand in the aerospace engine and defense markets, and has also introduced projections for 2026 based on continued growth in those sectors.
While the analyst continues to view ATI as a solid long-term cyclical growth story with meaningful exposure to aerospace and defense, the analyst notes that many near-term catalysts — such as multiple expansion following the April upgrade — have &#8220;quickly played out.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45523994/raytheon-boosts-us-military-defense-with-advanced-threat-tracking-radar" rel="noreferrer noopener">Raytheon Boosts US Military Defense With Advanced Threat-Tracking Radar</a>
As a result, despite the positive demand outlook, Gibbs sees a more balanced risk-reward profile in the near term.
Following the quarterly results, the analyst raised the 2025 EPS estimate to $3.07 from $2.82, aligning with ATI&#8217;s guidance of $2.87–$3.09.
Gibbs now projects EBITDA of $835 million versus prior $814 million, near the high end of the company&#8217;s $800 million–$840 million range, which remains conservative.
The company lifted its aerospace engine growth outlook to 15%–20%-plus year-over-year from 9%-plus, reflecting a richer product mix, while maintaining its low-single-digit airframe growth view, with lower titanium volumes offset by better pricing and mix.
Concerns about Russia&#8217;s potential return to the titanium market in a de-escalation scenario were eased by ATI&#8217;s new $1 billion airframe supply deal with&nbsp;&nbsp;Airbus SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EADSY#OTC">EADSY</a>), which runs from 2026 to 2030.
Some limited pressure is expected from softer demand in China for power generation and nuclear-related sales due to trade tensions, but tariffs now appear more manageable.
Gibbs also raised 2025 free cash flow to equity to $309 million from $297 million, driven by higher EBITDA, with net capex of $240 million based on gross capex of $270 million and $30 million in customer reimbursements.
The analyst established a 2026E EPS of $3.63 and EBITDA of $937 million.
ATI Price Action: ATI shares are trading lower by 1.96% to $75.09 at publication on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45503979/5-stocks-about-to-short-squeeze-as-market-rebounds" target="_blank" rel="noreferrer noopener">5 Stocks About To Short Squeeze As Market Rebounds</a></li>
</ul>
Photo: T. Schneider via Shuttestock

Trading Ideas

General

European Aeronautic Defence And Space Unsponsored

EADSY

ATI Downgrade: Analyst Cautious As Near-Term Catalysts 'Have Quickly Played Out'

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Keybanc analyst Philip Gibbs downgraded the rating for ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) from Overweight to Sector Weight. ATI shares closed at $76.58 on Monday. <a href="https://www.benzinga.com/quote/ATI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Arthur He downgraded Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) from Buy to Neutral. Prime Medicine shares closed at $1.3350 on Monday. <a href="https://www.benzinga.com/quote/PRME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Yun Kim downgraded MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) from Buy to Hold and lowered the price target from $350 to $190. MongoDB shares closed at $189.01 on Monday. <a href="https://www.benzinga.com/quote/AFRMDBM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Eric Joseph downgraded the rating for Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) from Overweight to Neutral. Prime Medicine shares closed at $1.3350 on Monday. <a href="https://www.benzinga.com/quote/PRME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Sison downgraded the rating for Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Overweight to Equal-Weight and cut the price target from $95 to $76. Westlake shares closed at $79.94 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratingsWLK">See how other analysts view this stock.</a></li>
</ul>
Considering buying MDB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="563" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-1024x563.png" alt="" class="wp-image-921180" style="width:670px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-1024x563.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-768x422.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246.png 1123w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45511338/home-depot-toll-brothers-and-3-stocks-to-watch-heading-into-tuesday">Home Depot, Toll Brothers And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Downgrades

Pre-Market Outlook

PRME

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Keybanc analyst Philip Gibbs downgrades ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) from Overweight to Sector Weight.

Keybanc Downgrades ATI to Sector Weight

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Pony AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares were up 48.36% after the company reportedly said it is getting closer to profitability and can build its <a href="https://www.benzinga.com//node/45049945" target="_blank" rel="noreferrer noopener">autonomous driving system for less</a>.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) stock rocketed 45.32% after the company announced a collaboration with Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) to offer a bundled package of all dose <a href="https://www.benzinga.com//node/45074872" target="_blank" rel="noreferrer noopener">strengths of Wegovy on its platform</a>. B of A Securities analyst raised the price <a href="https://www.benzinga.com/quote/hims/analyst-ratings" target="_blank" rel="noreferrer noopener">forecast from $22 to $26</a>.</li>
<li>ODDITY Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) shares surged 42.96% after the company reported better-than-expected first-quarter financial results, raised its FY25 guidance, and issued <a href="https://www.benzinga.com//node/45111584" target="_blank" rel="noreferrer noopener">second-quarter guidance above estimates</a>. Analysts raised price <a href="https://www.benzinga.com/quote/ODD/analyst-ratings" target="_blank" rel="noreferrer noopener">forecasts on the stock</a>.</li>
<li>Metsera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) stock escalated by 38.42% last week.</li>
<li>CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) stock increased 29.86% after the company announced that cretostimogene grenadenorepvec monotherapy data was presented at the American <a href="https://www.benzinga.com//node/45043205" target="_blank" rel="noreferrer noopener">Urological Association Annual Meeting</a>. Some analysts initiated coverage/ <a href="https://www.benzinga.com/quote/cgon/analyst-ratings" target="_blank" rel="noreferrer noopener">boosted the price forecast</a>.</li>
<li>Kiniksa Pharmaceuticals, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) shares upped 29.42% after raising <a href="https://www.benzinga.com//node/45063476" target="_blank" rel="noreferrer noopener">its FY25 sales guidance</a>.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) stock rose 27.34%.</li>
<li>Frontdoor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTDR#NASDAQ">FTDR</a>) shares were up 25.44% last week after the company reported better-than-expected first-quarter financial results and raised its FY25 <a href="https://www.benzinga.com//node/45130988" target="_blank" rel="noreferrer noopener">sales outlook</a>.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) stock increased 25.39% after it reported better-than-expected quarterly financial results and raised its <a href="https://www.benzinga.com//node/45130989" target="_blank" rel="noreferrer noopener">FY25 adjusted EPS guidance</a>.</li>
<li>Perdoceo Education Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) stock rose 23.72% after it <a href="https://www.benzinga.com//node/45149554" target="_blank" rel="noreferrer noopener">reported first-quarter results</a>.</li>
<li>iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) stock jumped 23.71% after it reported better-than-expected first-quarter results and <a href="https://www.benzinga.com//node/45149802" target="_blank" rel="noreferrer noopener">raised its FY25 sales guidance</a>.</li>
</ol>
Photo by Tada Images via Shutterstock

Mid Cap

CGON

FTDR

Hims & Hers Health, Inc. Class A Common Stock

HIMS

IRTC

KNSA

MTSR

PONY

PRDO

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Thursday.
Shares of CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) rose sharply during Thursday's session after the company reported better-than-expected first-quarter results and <a href="https://www.benzinga.com/quote/CVS/earnings">raised FY25 EPS guidance</a>.
CVS Health reported first-quarter sales of $94.59 billion on Thursday, beating the consensus of $93.64 billion. Total revenues increased 7% year over year, driven by revenue growth across all segments.
CVS Health posted adjusted EPS of $2.25 for Q1, a sharp rise from $1.31 a year earlier and well above Wall Street&#8217;s $1.70 estimate.
CVS Health shares jumped 6.5% to $71.11 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Cantor Equity Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEP#NASDAQ">CEP</a>) surged 28% to $53.98.</li>
<li>E2open Parent Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NASDAQ">ETWO</a>) shares jumped 26.4% to $2.4901.</li>
<li>CommScope Holding Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) gained 24.4% to $4.6550 following better-than-expected quarterly earnings.</li>
<li>MediaAlpha, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) rose 19.7% to $10.06 following strong quarterly sales.</li>
<li>Lotus Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) gained 19.6% to $1.9500.</li>
<li>Advanced Energy Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEIS#NASDAQ">AEIS</a>) rose 16.7% to $113.72 after the company reported better-than-expected first-quarter financial results and issued second-quarter sales guidance above estimates. Additionally, Needham maintained a Buy rating on the stock and Baird maintained an Outperform rating.</li>
<li>MYR Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYRG#NASDAQ">MYRG</a>) gained 16.2% to $142.09 following upbeat quarterly earnings.</li>
<li>CONMED Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) rose 16.1% to $57.01 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance.</li>
<li>CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) gained 15.3% to $47.60.</li>
<li>Chart Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) rose 14.2% to $154.11 after the company reported better-than-expected first-quarter adjusted EPS results and issued FY25 adjusted EPS guidance above estimates. Also, the company issued FY25 sales guidance with its midpoint above estimates.</li>
<li>TTM Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) gained 13.4% to $22.70 after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates.</li>
<li>Frontdoor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTDR#NASDAQ">FTDR</a>) rose 13.3% to $46.56 after the company reported better-than-expected first-quarter financial results and raised tis FY25 sales guidance above estimates.</li>
<li>Quanta Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) gained 12.4% to $329.11 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance with its midpoint above estimates.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) rose 12% to $60.87 after the company reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance.</li>
<li>Carrier Global Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) gained 10.4% to $69.07 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance.</li>
<li>Vertiv Holdings Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) rose 9.7% to $93.67.</li>
<li>Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) gained 9.6% to $433.29 following strong quarterly earnings.</li>
<li>MasTec, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) rose 8.2% to $137.75.</li>
<li>CNH Industrial N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNH#NYSE">CNH</a>) gained 8.2% to $12.52 following quarterly results.</li>
<li>Comfort Systems USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) jumped 7.4% to $427.31.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) gained 6.4% to $260.16.</li>
<li>Hyatt Hotels Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) rose 6.2% to $119.61 following upbeat results.</li>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) gained 5.6% to $580.00 following strong quarterly results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45135511/how-to-earn-500-a-month-from-apple-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Apple Stock Ahead Of Q2 Earnings</a> </li>
</ul>
Photo via Shutterstock

AEIS

CARR

CNMD

COMM

CRWV

CVNA

ETWO

GTLS

MSFT

MYRG

TTMI

CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday

ATI shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 adjusted EPS guidance.

CORRECTION: ATI Sees Q2 Adj EPS $0.67-$0.73 vs $0.68 Est; Sees Adj. EBITDA  $195M-$205M

ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) raises FY2025 Adj EPS guidance from $2.80-$3.00 to $2.87-$3.09 vs $2.86 analyst estimate..

ATI Raises FY2025 Adj EPS Guidance from $2.80-$3.00 to $2.87-$3.09 vs $2.86 Est

Press Releases

ATI Employees Ratify New Six-Year Agreement

ATI Announces First Quarter 2025 Results

ATI's Aerospace and Defense Leadership Recognized with GICS Code Update

ATI CEO Kim Fields to speak at Bernstein Strategic Decisions Conference

ATI signs multi-year agreement with Airbus for titanium plate, sheet and billet

ATI expands portfolio to produce Titanium Alloy Sheet for aerospace

ATI Announces Webcast for Second Quarter 2025 Results

GATX Corporation Adds Robert S. Wetherbee to Board of Directors

ATI Announces Second Quarter 2025 Results

ATI and Boeing extend and expand titanium supply long-term agreement

GATX

AeroVironment

Axon Enterprise

Boeing

BWX Technologies

Curtiss-Wright

Leonardo DRS

Embraer

General Dynamics Corporation Common Stock

General Dynamics

GE Aerospace

Heico

Heico Corporation Common Stock

Huntington Ingalls Industries, Inc. Common Stock

Huntington Ingalls Indus

Howmet Aerospace

Karman Holdings

Kratos Defense & Security Solutions, Inc. - Common Stock

Kratos Defense & Security

L3Harris Technologies

Lockheed Martin

Loar Holdings

Moog Inc. Class B Common Stock

Northrop Grumman Corporation Common Stock

Northrop Grumman

Rocket Lab

Transdigm Group Incorporated Common Stock

TransDigm Gr

Textron

Woodward

Susquehanna

Benchmark

Barclays

Deutsche Bank

JP Morgan

Comments

ATI

Noticias

Últimas noticias sobre ATI (NYSE:ATI) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL